PI-RADS: where next?
B Turkbey, AS Purysko - Radiology, 2023 - pubs.rsna.org
Prostate MRI plays an important role in the clinical management of localized prostate
cancer, mainly assisting in biopsy decisions and guiding biopsy procedures. The Prostate …
cancer, mainly assisting in biopsy decisions and guiding biopsy procedures. The Prostate …
Early detection of prostate cancer: AUA/SUO guideline part II: considerations for a prostate biopsy
JT Wei, D Barocas, S Carlsson, F Coakley… - Journal of …, 2023 - journals.lww.com
Purpose: The summary presented herein covers recommendations on the early detection of
prostate cancer and provides a framework to facilitate clinical decision-making in the …
prostate cancer and provides a framework to facilitate clinical decision-making in the …
[HTML][HTML] Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
FC Hamdy, JL Donovan, JA Lane… - … England Journal of …, 2023 - Mass Medical Soc
Background Between 1999 and 2009 in the United Kingdom, 82,429 men between 50 and
69 years of age received a prostate-specific antigen (PSA) test. Localized prostate cancer …
69 years of age received a prostate-specific antigen (PSA) test. Localized prostate cancer …
[HTML][HTML] Prostate cancer screening with PSA and MRI followed by targeted biopsy only
J Hugosson, M Månsson, J Wallström… - … England Journal of …, 2022 - Mass Medical Soc
Background Screening for prostate cancer is burdened by a high rate of overdiagnosis. The
most appropriate algorithm for population-based screening is unknown. Methods We invited …
most appropriate algorithm for population-based screening is unknown. Methods We invited …
Artificial intelligence and radiologists at prostate cancer detection in mri—the pi-cai challenge
We hypothesized that state-of-the-art AI models, trained using thousands of patient cases,
are non-inferior to radiologists at clinically significant prostate cancer diagnosis using MRI …
are non-inferior to radiologists at clinically significant prostate cancer diagnosis using MRI …
[HTML][HTML] Guidelines for genetic testing in prostate cancer: a scoping review
Background Genetic testing, to identify pathogenic or likely pathogenic variants in prostate
cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform …
cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform …
[HTML][HTML] Clinical characterization of patients diagnosed with prostate cancer and undergoing conservative management: a PIONEER analysis based on big data
Background Conservative management is an option for prostate cancer (PCa) patients
either with the objective of delaying or even avoiding curative therapy, or to wait until …
either with the objective of delaying or even avoiding curative therapy, or to wait until …
Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: Performance of a fully automated AI‐algorithm for lesion detection …
B Oerther, H Engel, A Nedelcu, CL Schlett… - The …, 2023 - Wiley Online Library
Abstract Background Multiparametric MRI (mpMRI) improves the detection of aggressive
prostate cancer (PCa) subtypes. As cases of active surveillance (AS) increase and tumor …
prostate cancer (PCa) subtypes. As cases of active surveillance (AS) increase and tumor …
MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer
M Alabousi, S Ghai, MA Haider - Radiology, 2023 - pubs.rsna.org
Two cases involving patients diagnosed with localized prostate cancer and treated with MRI-
guided focal therapies are presented. Patient selection procedures, techniques, outcomes …
guided focal therapies are presented. Patient selection procedures, techniques, outcomes …
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients
W Ebrahimizadeh, KP Guérard, S Rouzbeh… - British Journal of …, 2023 - nature.com
Background Distinguishing between true indolent and potentially life-threatening prostate
cancer is challenging in tumours displaying clinicopathologic features associated with low or …
cancer is challenging in tumours displaying clinicopathologic features associated with low or …